• Matica Biotech Names Dr. Yun Jeong Song as CEO contractpharma
    May 14, 2021
    Song's background spans more than 20 years of basic research, patient care and biopharmaceutical industry leadership.
  • Carmine Therapeutics appoints Don Haut as CEO prnasia
    May 08, 2021
    Carmine Therapeutics, Inc., an emerging leader in gene therapy, announced that Don Haut, PhD has been appointed as its Chief Executive Officer, and member of the Board of Directors.
  • Prashant Nagre appointed as MD of Fermenta Biotech expresspharma
    May 08, 2021
    Krishna Datla, Promoter and MD of Fermenta Biotech announced the appointment of CEO, Prashant Nagre, as the new MD with effect from May 9, 2021. Datla will continue as a Board member and the Executive Vice Chairman.
  • GS1 India elevates S. Swaminathan as CEO expresspharma
    April 13, 2021
    Prior to his elevation, Swaminathan was the Chief Operating Officer and successfully led the Business Development and Industry Engagement departments at GS1 India, in the last decade.
  • Rentschler Biopharma Names Martin Kessler as New CEO in U.S. contractpharma
    April 01, 2021
    Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed of Dr. Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as ...
  • LabVantage Solutions Names Mikael Hagstroem as CEO contractpharma
    March 26, 2021
    LabVantage Solutions, Inc., a provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, has appointed Mikael Hagstroem as chief executive officer. ...
  • Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 years expresspharma
    March 25, 2021
    Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.
  • Fulcrum Therapeutics Announces CEO Transition americanpharmaceuticalreview
    March 09, 2021
    Fulcrum Therapeutics announced Bryan E. Stuart, the company’s chief operating officer, will become Fulcrum’s president and chief executive officer and will be appointed to the Board of Directors. Stuart will succeed current president and ...
  • Aevitas Therapeutics Appoints President and CEO contractpharma
    February 23, 2021
    Dr. Markus Peters offers a 25-year track record of developing and commercializing orphan and specialty pharmaceuticals.
  • BioDuro-Sundia Appoints CEO contractpharma
    February 10, 2021
    Haijun Dong to lead the company into the next phase of growth as a leading CRDMO in the industry.
PharmaSources Customer Service